- Home
- NSPR vs JMM Comparison
NSPR vs JMM Comparison
Compare NSPR & JMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSPR
- JMM
- Stock Information
- Founded
- NSPR 2005
- JMM 1988
- Country
- NSPR Israel
- JMM United States
- Employees
- NSPR N/A
- JMM N/A
- Industry
- NSPR Medical/Dental Instruments
- JMM Trusts Except Educational Religious and Charitable
- Sector
- NSPR Health Care
- JMM Finance
- Exchange
- NSPR Nasdaq
- JMM Nasdaq
- Market Cap
- NSPR 63.0M
- JMM 58.2M
- IPO Year
- NSPR N/A
- JMM N/A
- Fundamental
- Price
- NSPR $3.19
- JMM $6.03
- Analyst Decision
- NSPR Strong Buy
- JMM
- Analyst Count
- NSPR 2
- JMM 0
- Target Price
- NSPR $4.75
- JMM N/A
- AVG Volume (30 Days)
- NSPR 50.3K
- JMM 16.1K
- Earning Date
- NSPR 03-05-2025
- JMM 01-01-0001
- Dividend Yield
- NSPR N/A
- JMM 5.44%
- EPS Growth
- NSPR N/A
- JMM N/A
- EPS
- NSPR N/A
- JMM N/A
- Revenue
- NSPR $6,821,000.00
- JMM N/A
- Revenue This Year
- NSPR $13.36
- JMM N/A
- Revenue Next Year
- NSPR $49.64
- JMM N/A
- P/E Ratio
- NSPR N/A
- JMM N/A
- Revenue Growth
- NSPR 24.70
- JMM N/A
- 52 Week Low
- NSPR $1.81
- JMM $5.29
- 52 Week High
- NSPR $3.42
- JMM $6.10
- Technical
- Relative Strength Index (RSI)
- NSPR 63.51
- JMM 45.97
- Support Level
- NSPR $2.60
- JMM $6.01
- Resistance Level
- NSPR $3.11
- JMM $6.13
- Average True Range (ATR)
- NSPR 0.28
- JMM 0.08
- MACD
- NSPR 0.05
- JMM -0.00
- Stochastic Oscillator
- NSPR 87.15
- JMM 10.53
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About JMM Nuveen Multi-Market Income Fund (MA)
Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities including, but not limited to residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.